肝癌共病抑郁分子机制的研究进展

doi:10.11904/j.issn.1002-3070.2022.03.008

实用肿瘤学杂志 ›› 2022, Vol. 36 ›› Issue (3): 239-244.doi: 10.11904/j.issn.1002-3070.2022.03.008

肝癌共病抑郁分子机制的研究进展

唐如冰¹, 王琪^2,3 综述, 游雪梅^1,3 审校

1.广西医科大学附属肿瘤医院肝胆外科(南宁 530021);
2.广西医科大学附属肿瘤医院实验研究部;
3.区域性高发肿瘤早期防治研究教育部重点实验室(广西医科大学)

收稿日期:2021-08-25 修回日期:2021-09-23 出版日期:2022-06-28 发布日期:2022-06-28
通讯作者: 游雪梅,E-mail:youxuemei@stu.gxmu.edu.cn
作者简介:唐如冰,女,(1997-),硕士研究生,从事肿瘤心理相关的研究。
基金资助:
国家自然科学基金项目(编号:81960308)

Research progress in molecular mechanism of liver cancer comorbid and depression

TANG Rubing¹, WANG Qi^2,3, YOU Xuemei^1,3

1. Department of Hepatobiliary Surgery,The Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China;
2. Department of Experimental Research,The Affiliated Tumor Hospital of Guangxi Medical University;3.Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education

Received:2021-08-25 Revised:2021-09-23 Online:2022-06-28 Published:2022-06-28

摘要/Abstract

摘要： 肝癌患者共病抑郁的发生率极高,且抑郁是影响肝癌患者预后的不良因素。了解肝癌共病抑郁的分子机制对疾病的诊断和治疗至关重要。因此,本文以两者涉及的发病机制为出发点,结合现有的研究成果,从自主神经功能紊乱、下丘脑-垂体-肾上腺(Hypothalamic-pituitary-adrenal,HPA)轴功能异常、炎症因子比例失调、5-羟色胺(5-hydroxytryptamine,5-HT)系统调节异常、肠道菌群失调和氧化应激反应六个方面就两者共病的分子机制研究进展做一综述。

关键词: 肝癌, 抑郁, 共病, 分子机制

Abstract: The incidence of comorbid depression in patients with liver cancer is extremely high.The depression is an adverse factor affecting the prognosis of liver cancer patients.Understanding the molecular mechanism of liver cancer comorbid and depression is crucial for the diagnosis and treatment of the disease.Therefore,this paper reviews the pathogenesis involved in both as a starting point and combines the existing research results from autonomic dysfunction,hypothalamic-pituitary-adrenal(HPA)axis dysfunction,inflammatory cytokines imbalance,abnormal regulation of 5-hydroxytryptamine(5-HT)system,imbalance of intestinal flora,and oxidative stress are reviewed.

Key words: Liver cancer, Depression, Comorbidities, Molecular mechanism

中图分类号:

R735.7

唐如冰, 王琪, 游雪梅. 肝癌共病抑郁分子机制的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 239-244.

TANG Rubing, WANG Qi, YOU Xuemei. Research progress in molecular mechanism of liver cancer comorbid and depression[J]. Journal of Practical Oncology, 2022, 36(3): 239-244.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.03.008

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I3/239

参考文献

1 International Agency for Research on Cancer.The global cancer observatory.2020[EB/OL].[2020-07-01].https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf.
2 Malhi GS,Mann JJ.Depression[J].Lancet,2018,392(10161):2299-2312.
3 Jin SH,Tian J.Prevalence of anxiety and depression and their risk factors in Chinese cancer patients[J].Supportive Care Cancer,2013,22(2):453-459.
4 韦珏伶,向骁,赵凌云,等.HSP90AA1/HSPA8在合并抑郁情绪的肝癌患者中的表达及临床意义[J].中国肿瘤,2019,28(5):387-394.
5 赵凌云,韦珏伶,赵新华,等.巴塞罗那(BCLC)B/C期肝癌患者术前抑郁相关因素分析及对免疫功能的影响[J].现代肿瘤医学,2018,26(11):1727-1732.
6 贾勇.抑郁与肝癌发生、复发风险的相关性研究[D].长春:吉林大学,2019.
7 Dai S,Mo Y,Wang Y,et al.Chronic stress promotes cancer development[J].Front Oncol,2020,10:1492.
8 Lake CR,Pickar D,Ziegler MG,et al.High plasma norepinephrine levels in patients with major affective disorder[J].Am J Psychiatry,1982,139(10):1315-1318.
9 Mravec B,Horvathova L,Hunakova L.Neurobiology of cancer:the role of β-adrenergic receptor signaling in various tumor environments[J].Int J Mol Sci,2020,21(21):1-24.
10 Jiang W,Li Y,Li ZZ,et al.Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling[J].Brain,Behav Immu,2019,80:825-838.
11 Jiang W,Li Y,Wei W,et al.Spleen contributes to restraint stress induced hepatocellular carcinoma progression[J].Int Immunopharmacol,2020,83:106420.
12 Lin XH,Liu HH,Hsu SJ,et al.Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop[J].J Clin Cancer Res,2020,39(1):64-80.
13 沈锋,林间,王海波.肝细胞癌免疫微环境研究进展及未来方向[J].中国实用外科杂志,2021,41(1):42-47.
14 Reiche EM,Nunes SO,Morimoto HK.Stress,depression,the immune system,and cancer[J].Lancet Oncol,2004,5(10):617-625.
15 Zhao Y,Jia Y,Shi T,et al.Depression promotes hepatocellular carcinoma progression through a glucocorticoids mediated up-regulation of PD-1 expression in tumor infiltrating NK Cells[J].Carcinogenesis,2019,40(9):1132-1141.
16 Feng Z,Liu L,Zhang C,et al.Chronic restraint stress attenuates p53 function and promotes tumorigenesis[J].Proc Natl Acad Sci U S A,2012,109(18):7013-7018.
17 Marra F,Tacke F.Roles for chemokines in liver disease[J].Gastroenterology,2014,147(3):577-594.
18 Wohleb ES,Franklin T,Iwata M,et al.Integrating neuroimmune systems in the neurobiology of depression[J].Nat Rev Neurosci,2016,17(8):497-511.
19 Fan N,Luo Y,Ou Y,et al.Altered serum levels of TNF-α,IL-6,and IL-18 in depressive disorder patients[J].Hum Psychopharmacol,2017,32(4):1002.
20 Carboni L,McCarthy DJ,Delafont B,et al.Biomarkers for response in major depression:comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies[J].Transl Psychiatry,2019,9(1):182-193.
21 Jin K,Lu J,Yu Z,et al.Linking peripheral IL-6,IL-1β and hypocretin-1 with cognitive impairment from major depression[J].J Affect Disord,2020,277:204-211.
22 Tartour E,Pere H,Maillere B,et al.Angiogenesis and immunity:a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy[J].Cancer Metastasis Rev,2011,30(1):83-95.
23 Voronov E,Shouval D,Krelin Y,et al.IL-1 is required for tumor invasiveness and angiogenesis[J].Proc Natl Acad Sci U S A,2003,100(5):2645-2650.
24 Hammam O,Mahmoud O,Zahran M,et al.A possible role for TNF-α in coordinating inflammation and angiogenesis in chronic liver disease and hepatocellular carcinoma[J].Gastrointest Cancer Res,2013,6(4):107-114.
25 赵凤娟,王琪,赵新华,等.抑郁介导肿瘤免疫微环境诱导肝癌不良预后研究[J].中国肿瘤,2021,30(3):234-240.
26 Illman J,Corringham R,Robinson D,et al.Are inflammatory cytokines the common link between cancer-associated cachexia and depression[J].J Support Oncol,2005,3(1):37-50.
27 Adinolfi LE,Nevola R,Rinaldi L,et al.Chronic hepatitis C virus infection and depression[J].Clin Liver Dis,2017,21(3):517-534.
28 Lesurtel M,Graf R,Aleil B,et al.Platelet-derived serotonin mediates liver regeneration[J].Science,2006,312(5770):104-107.
29 Soll C,Jang JH,Riener M,et al.Serotonin promotes tumor growth in human hepatocellular cancer[J].Hepatology,2010,51(4):1244-1254.
30 马韵涵,潘宇飞,董立巍,等.5-羟色胺可促进肝细胞癌的发生与发展[J].肿瘤,2016,36(5):521-529.
31 Pyroja S,Joseph B,Paulose C.Increased 5-HT2C receptor binding in the brain stem and cerebral cortex during liver regeneration and hepatic neoplasia in rats[J].J Neurol Sci,2007,254(1/2):3-8.
32 Zhang H,Xu H,Tang Q,et al.The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells[J].Anticancer Drugs,2021,32(8):793-801.
33 Chen V,Lu M,Yang Y,et al.Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy:a population-based cohort study[J].J Affect Disord,2019,253:147-153.
34 Li＇ skiewicz P,Kaczmarczyk M,Misiak B,et al.Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder[J].Prog Neuropsychopharmacology Biol Psychiatry,2021,106:110076.
35 Pennisi E.Gut bacteria linked to mental well-being and depression[J].Science,2019,363(6427):569.
36 Butler M,Cryan J,Dinan T.Man and the microbiome:A new theory of everything[J].Annu Rev Clin Psychol,2019,15(1):371-398.
37 Schmidt C.Mental health:thinking from the gut[J].Nature,2015,518(7540):12-15.
38Golonka RM,Vijay-Kumar M.Atypical immunometabolism and metabolic reprogramming in liver cancer:Deciphering the role of gut microbiome[J].Adv Cancer Res,2021,149:171-255.
39 Stevens BR,Goel R,Seungbum K,et al.Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression[J].Gut,2018,67(8):1555-1557.
40 Tripathi A,Debelius J,Brenner DA,et al.The gut-liver axis and the intersection with the microbiome[J].Nat Rev Gastroenterol Hepatol,2018,15(7):397-411.
41 Dapito D,Mencin A,Gwak G,et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J].Cancer Cell,2012,21(4):504-516.
42 Zhang HL,Yu LX,Yang W,et al.Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats[J].J Hepatol,2012,57(4):803-812.
43 Ferrere G,Wrzosek L,Cailleux F,et al.Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice[J].J Hepatol,2017,66(4):806-815.
44 Reiter A,Bengesser SA,Hauschild AC,et al.Interleukin-6 gene expression changes after a 4-week intake of a multispecies probiotic in major depressive disorder-preliminary results of the PROVIT study[J].Nutrients,2020,12(9):2575-2592.
45 Bhatt S,Nagappa AN,Patil CR.Role of oxidative stress in depression[J].Drug Discov Today,2020,25(7):1270-1276.
46 Leone V,Ali A,Weber A,et al.Liver inflammation and hepatobiliary cancers[J].Trends Cancer,2021,7(7):606-623.
47 Reuter S,Gupta SC,Chaturvedi MM,et al.Oxidative stress,inflammation,and cancer:how are they linked[J].Free Radic Biol Med,2010,49(11):1603-1616.

[1]	庞春华, 李繁荣, 唐如冰, 覃蕾, 赵新华, 唐娟, 游雪梅. 术前疲乏状态与中晚期肝细胞癌患者术后生活质量的关联性:一项前瞻性队列研究[J]. 实用肿瘤学杂志, 2022, 36(2): 127-132.
[2]	任凤海, 朱开彬, 王彦博, 周福成, 庞赛楠, 陈澜涛. NFATc1对人肺腺癌细胞增殖、凋亡和侵袭能力的影响[J]. 实用肿瘤学杂志, 2021, 35(5): 402-407.
[3]	陈雪健, 王伟, 周健, 李宁, 张浩鹏, 徐力善. 瑞戈非尼联合哌立福辛诱导人肝癌HepG2细胞凋亡的分子机制研究[J]. 实用肿瘤学杂志, 2021, 35(5): 408-413.
[4]	朱云芳, 陈杨, 朱林芳, 石青萍, 成会荣, 任思颖, 文洪梅. 2016年云南省肿瘤登记地区肝癌发病和死亡情况及2011—2016年变化趋势[J]. 实用肿瘤学杂志, 2021, 35(2): 97-102.
[5]	胡启辉, 杜毅超, 贺凯, 付文广, 夏先明. 内质网应激在肝癌中的作用[J]. 实用肿瘤学杂志, 2021, 35(2): 160-164.
[6]	白明宇, 陈丽莉. 2015—2019年营口市城市居民肝癌死因分析[J]. 实用肿瘤学杂志, 2020, 34(6): 500-503.
[7]	石琳娜, 隋红. 原发性肝癌免疫检查点抑制剂治疗的进展与挑战[J]. 实用肿瘤学杂志, 2020, 34(6): 560-564.
[8]	韩静, 蒲艳, 柳惠斌. SKA1对肾细胞癌细胞增殖凋亡的影响及其分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(5): 404-411.
[9]	张孟哲, 康向东. Krüpple样转录因子4与结肠癌发生发展关系的研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 456-459.
[10]	赵仁成, 林子棠, 余卫军, 雷林, 刘峥, 徐英, 郭艳芳, 彭绩. 2017—2019年深圳市宝安区40~74岁常住居民五癌风险流行状况分析[J]. 实用肿瘤学杂志, 2020, 34(4): 315-320.
[11]	周健, 陈雪健, 王伟, 李宁, 孙振宇, 徐力善. 沉默PRMT5基因对人肝癌细胞生物学行为的影响[J]. 实用肿瘤学杂志, 2020, 34(3): 208-213.
[12]	陈澜涛, 颜巍, 刘静蕾, 姚磊. 防己诺林碱对肺癌H1299和A549细胞的作用及其分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(2): 126-132.
[13]	刘光霞, 赵连春, 陈芳, 贾乾, 高伟, 侯瞻, 卢亚敏. ZCCHC12对甲状腺细胞恶性转化的影响与作用机制[J]. 实用肿瘤学杂志, 2020, 34(2): 133-138.
[14]	张从义, 崔逸峰, 李宝宝, 刘连新. 细胞分裂周期7蛋白在肝癌组织的表达及其对肝癌细胞增殖和侵袭的影响[J]. 实用肿瘤学杂志, 2020, 34(2): 150-155.
[15]	陈子印, 白艳春, 曹洋森, 李坚, 徐丽丽, 赵秋爽, 汪洋. 呼吸门控技术在肝癌大分割放射治疗方面的剂量学优势[J]. 实用肿瘤学杂志, 2019, 33(6): 536-539.

肝癌共病抑郁分子机制的研究进展

Research progress in molecular mechanism of liver cancer comorbid and depression

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价